ZNTL · Zentalis Pharmaceuticals, Inc.

$3.56 -0.59 (-14.22%) At close · Aug 14

Market Cap

$255.15M

71.67M

The company's filings as submitted to the SEC's EDGAR system — 10-K, 10-Q, 8-K, proxy statements and more — listed most recent first.

Type	Filing Date	Period
8-K	2026-08-14	2026-08-13
10-Q	2026-08-06	2026-06-30
8-K	2026-08-06	—
Investor Event Transcript	2026-06-30	—
8-K	2026-06-18	2026-06-16
Investor Event Transcript	2026-06-03	2026-06-30
8-K	2026-05-27	2026-05-22
8-K	2026-05-21	—
10-Q	2026-05-12	2026-03-31
8-K	2026-05-12	—
8-K	2026-05-05	—
DEF 14A	2026-04-30	2026-06-16
8-K	2026-04-17	—
8-K	2026-04-09	—
8-K	2026-03-26	—
10-K	2026-03-26	2025-12-31
8-K	2026-01-09	2026-01-06
8-K	2025-12-15	—
8-K	2025-11-10	—
10-Q	2025-11-10	2025-09-30
8-K	2025-08-26	—
8-K	2025-08-06	—
10-Q	2025-08-06	2025-06-30
8-K	2025-06-18	2025-06-17
8-K	2025-06-02	2025-05-31
8-K	2025-05-20	—
10-Q	2025-05-14	2025-03-31
8-K	2025-05-14	—
DEF 14A	2025-04-30	2025-06-17
8-K	2025-04-28	2025-04-27
10-K	2025-03-26	2024-12-31
8-K	2025-03-26	—
8-K	2025-03-17	2025-03-15
8-K	2025-01-29	—
8-K	2025-01-28	2025-01-22
8-K/A	2024-12-19	2024-12-17
8-K	2024-11-13	2024-11-12
10-Q	2024-11-12	2024-09-30
8-K	2024-09-16	—
8-K	2024-08-09	—
10-Q	2024-08-09	2024-06-30
8-K	2024-06-21	—
8-K	2024-06-03	—
8-K	2024-05-29	2024-05-24
8-K	2024-05-07	—
10-Q	2024-05-07	2024-03-31
DEF 14A	2024-04-29	2024-06-21
8-K	2024-04-11	2024-04-05
8-K	2024-04-09	—
10-K	2024-02-27	2023-12-31

Showing 1–50 of 126 filings

Key facts CIK 1725160 CUSIP 98943L107 13F (30d) 114 filings 111 filers Visit website Investor relations